FDA Drug Safety Communication: FDA to review study examining use of oral fluconazole (Diflucan) in pregnancy
The U.S. Food and Drug Administration (FDA) is evaluating the results of a Danish study1 that concludes there is a possible increased risk of miscarriage with the use of oral fluconazole (Diflucan) for yeast infections.
Source: FDA Center for Drug Evaluation and Research - What's New - Category: Drugs & Pharmacology Source Type: news
More News: Drugs & Pharmacology | Fluconazole | Food and Drug Administration (FDA) | Miscarriage | Pregnancy | Study